Fonti utilizzate nella revisione corrente
Baer, J. (2017 agosto 11). Linee guida AACE e EAS sui lipidi. American College of Cardiology. Disponibile online all’indirizzo https://www.acc.org/latest-in-cardiology/articles/2017/08/11/08/35/aace-and-eas-lipid-guidelines. Accessed March 2019.
Nordestgaard, B. (2017). Un test nel contesto: Profilo lipidico, a digiuno rispetto al non digiuno. Medscape da J Am Coll Cardiol. 2017;70(13):1637-1646. Disponibile online all’indirizzo https://www.medscape.com/viewarticle/887480. Accessed March 2019.
Lozano, P. et. al. (2016 agosto 9). Screening dei lipidi nell’infanzia e nell’adolescenza per la rilevazione dell’ipercolesterolemia familiare Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016;316 (6):645-655. Disponibile online all’indirizzo https://jamanetwork.com/journals/jama/fullarticle/2542641. Accessed March 2019.
Bibbins-Domingo, K. et. al. (2016 novembre 15). Uso della statina per la prevenzione primaria delle malattie cardiovascolari negli adulti. US Preventive Services Task Force Recommendation Statement. JAMA. 2016; 316(19):1997-2007. Disponibile online all’indirizzo https://jamanetwork.com/journals/jama/fullarticle/2584058. Accessed March 2019.
Genzen, J. (2018 agosto, aggiornato). Marcatori di rischio tradizionali della malattia cardiovascolare aterosclerotica (ASCVD) – Marcatori di rischio delle malattie cardiovascolari (tradizionali). ARUP Consult. Disponibile online all’indirizzo https://arupconsult.com/content/cardiovascular-disease-traditional-risk-markers. Accessed March 2019.
Lloyd-Jones, D. et. al. (2017 ottobre). 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk, A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. JACC v 70 (14) ottobre 2017. Disponibile online all’indirizzo http://www.onlinejacc.org/content/70/14/1785. Accessed March 2019.
Pokharel, Y. et. al. (2017 aprile). Adozione della 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide. JAMA Cardiol. 2017;2(4):361-369. Disponibile online all’indirizzo https://jamanetwork.com/journals/jamacardiology/fullarticle/2606432. Accessed March 2019.
Jackson, E. (2017 September 5). Raccomandazioni ACC 2017 per la terapia non statica. American College of Cardiology. Disponibile online all’indirizzo https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2017/09/05/10/03/2017-focused-update-of-the-2016-acc-expert-consensus-nonstatin. Accessed March 2019.
Pallozola, V. et. al. (2018 aprile 24). Le principali linee guida sulle dislipidemie e le loro discrepanze: A Need for Consensus. American College of Cardiology. Disponibile online all’indirizzo https://www.acc.org/latest-in-cardiology/articles/2018/04/24/08/56/major-dyslipidemia-guidelines-and-their-discrepancies. Accessed March 2019.
(2016 novembre, aggiornato). Final Recommendation Statement Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Medicina preventiva. U.S. Preventive Services Task Force. Disponibile online all’indirizzo https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/statin-use-in-adults-preventive-medication1. Accessed March 2019.
(2017 October 31, Updated). Far controllare il colesterolo. Centers for Disease Control and Prevention. Disponibile online all’indirizzo https://www.cdc.gov/cholesterol/cholesterol_screening.htm. Accessed March 2019.
(2017 April 30, Updated). Come fare il test del colesterolo. American Heart Association. Disponibile online all’indirizzo https://www.heart.org/en/health-topics/cholesterol/how-to-get-your-cholesterol-tested. Accessed March 2019.
Fonti utilizzate nelle revisioni precedenti
Sommario esecutivo del terzo rapporto del National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA (2001) 285: 2486-2497.
(settembre 2002) National Heart, Lung, Blood Institute. Linee guida del National Cholesterol Education Program, Colesterolo, ATP III. II.3-b, II.9-c. PDF disponibile per il download all’indirizzo http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf . Accesso giugno 2009.
American Heart Association. Guida alla prevenzione primaria delle malattie cardiovascolari: Intervento a rischio, Gestione dei lipidi nel sangue. Disponibile online all’indirizzo http://www.americanheart.org/presenter.jhtml?identifier=4704. Accessed June 2009.
(Updated December 19, 2008) American Heart Association. Cosa significano i tuoi livelli di colesterolo. Disponibile online all’indirizzo http://www.americanheart.org/presenter.jhtml?identifier=183#HDL. Accesso maggio 2009.
Accademia americana dei medici di famiglia. Colesterolo: cosa significa il tuo livello. (Aggiornato a ottobre 2007). Disponibile online all’indirizzo http://familydoctor.org/online/famdocen/home/common/heartdisease/risk/029.html. Accessed September 2008.
(May 12, 2008) MedlinePlus Medical Encyclopedia. Profilo di rischio coronarico. Disponibile online all’indirizzo http://www.nlm.nih.gov/medlineplus/ency/article/003491.htm. Accessed October 2008.
ARUP Consult. Guida per i medici. Pannello lipidico, esteso. Disponibile online all’indirizzo http://www.aruplab.com/guides/ug/tests/0020468.jsp. Accessed October 2008.
Clarke, W. and Dufour, D. R., Editors (2006). Pratica contemporanea in chimica clinica. AACC Press. Washington, DC. Pp 251-253.
Pagana K, Pagana T. Mosby’s Manual of Diagnostic and Laboratory Tests. 3a edizione, St. Louis: Mosby Elsevier; 2006. Pp 351-356.
Davidson M, et al. Clinical Utility of Inflammatory Markers and Advanced Lipid Testing: Consigli da un gruppo di esperti di specialisti lipidici. Journal of Clinical Lipidology 2011 Sep; 5(5): 338-67.
Terzo rapporto del National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Settembre 2002. PDF disponibile per il download all’indirizzo http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf. Accesso ottobre 2012.
(©2012) American Heart Association. Livelli di colesterolo. Disponibile online all’indirizzo http://www.heart.org/HEARTORG/Conditions/Cholesterol/Cholesterol_UCM_001089_SubHomePage.jsp. Accessed October 2012.
(Novembre 2012) American Association of Family Physicians. Colesterolo alto. Disponibile online all’indirizzo http://familydoctor.org/familydoctor/en/diseases-conditions/high-cholesterol.html. Accessed October 2012.
Kavey R-EW, et al. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Relazione riassuntiva. Pediatria 2011; 128: DOI:10.1542/peds.2009-2107C. PDF disponibile per il download all’indirizzo http://pediatrics.aappublications.org/site/misc/2009-2107.pdf. Accesso ottobre 2012.
KidsHealth.org. Il colesterolo e il tuo bambino. Disponibile online all’indirizzo http://kidshealth.org/parent/medical/heart/cholesterol.html#. Accessed October 2012.
CDC. FASTSTATS – Le principali cause di morte (dati 2009). Disponibile online all’indirizzo http://www.cdc.gov/nchs/fastats/lcod.htm. Accessed October 2012.
KidsHealth.org. Il colesterolo e il tuo bambino. Disponibile online all’indirizzo http://kidshealth.org/parent/medical/heart/cholesterol.html#. Accessed October 2012.
(2006) Sekar K. Increased Small Low-Density Lipoprotein Particle Number, A Prominent Feature of the Metabolic Syndrome in the Framingham Heart Study. Circolazione. Disponibile online all’indirizzo http://circ.ahajournals.org/content/113/1/20.full. Accessed October 2012.
(September 23, 2002) Blake G, et al. Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women. Circulation, disponibile online all’indirizzo http://circ.ahajournals.org/content/106/15/1930.full. Accessed October 2012.
Blakenstein R, et al. Predittori di eventi di malattia cardiaca coronarica tra persone asintomatiche con basso colesterolo lipoproteico a bassa densità. Journal of the American College of Cardiology Volume 58, Issue 4, 19 luglio 2011, Pp 364-374.
Krauss R. Lipoprotein subfractions and cardiovascular disease risk. Curr Opin Lipidol 2010 Aug;21(4):305-11. Abstract disponibile online all’indirizzo http://www.ncbi.nlm.nih.gov/pubmed/20531184. Accessed October 2012.
Prado K, et al. Low-density lipoprotein numero di particelle predice calcificazione dell’arteria coronarica in adulti asintomatici a rischio intermedio di malattia cardiovascolare. J Clin Lipidol 2011 Sep-Oct;5(5):408-13. Abstract disponibile online all’indirizzo http://www.ncbi.nlm.nih.gov/pubmed/21981843. Accessed October 2012.
(May 2012) Lavie C, et.al. To B or Not to B: Is Non-High-Density Lipoprotein Cholesterol an Adequate Surrogate for Apolipoprotein B? Mayo Clin Proc. 2010 maggio; 85(5): 446-450. Disponibile online all’indirizzo http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861974/. Accessed October 2012.
Reviewer maggio 2015, Shannon Haymond, PhD, DABCC, FACB, Northwestern University Feinberg School of Medicine.
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934.
UpToDate: (2 maggio 2014) Pignone, Michael. Trattamento dei lipidi (inclusa l’ipercolesterolemia) nella prevenzione primaria. Accessed 05/12/15.
(Nov 17, 2014) American Heart Association. Capire le nuove linee guida di prevenzione. Disponibile online all’indirizzo http://www.heart.org/HEARTORG/Conditions/Understanding-the-New-Prevention-Guidelines_UCM_458155_Article.jsp. Accessed 05/12/15.
(Jan 2013) National Heart, Lung and Blood Institute. Linee guida integrate per la salute cardiovascolare e la riduzione del rischio nei bambini e negli adolescenti. Disponibile online all’indirizzo http://www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines. Accesso 05/14/15.